Cytomegalovirus (CMV)

Description

Cytomegalovirus Antibody (CMV) can precipitate and exacerbate gastrointestinal mucosal injury. Studies suggest that IHC performed on infected tissue with monoclonal antibodies directed against the CMV immediate early antigen is considered by most to be the current gold standard for diagnosis. This antibody is a mixture of two monoclonal antibodies that reacts with immediate early and early protein antigens in tissues infected with cytomegalovirus. Studies indicate that this antibody does not react with herpes virus or human papilloma virus (HPV). In the later stage of infection, a cytoplasmic reaction may be observed.

SPECIFICATIONS

Specifications

WEIGHT N/A
DIMENSIONS N/A
INTENDED USE ASR
SOURCE Mouse Monoclonal
CLONE DT10 + BC90
ISOTYPE IgG2a + IgG1
ANTIGEN Cytomegalovirus proteins
LOCALIZATION Nuclear staining pattern with some cytoplasmic staining
POSITIVE CONTROL CMV infected tissues
DATASHEETS & SDS
Download Data Sheet
Download ASR Data Sheet
Download RUO Data Sheet for International
Download SDS Sheet

Regulatory Notice: Biocare’s IVD-labeled products comply with US-FDA and European IVDD regulation. Other regions may have additional requirements for such labeling, please contact your local distributor.

REFERENCES

1. Vago L, et al. Acta Neuropathol. 1996 Oct; 92(4):404-8.
2. Mills AM, et al. Am J Surg Pathol. 2013 Jul; 37(7):995-1000. 3. Kandiel A, Lashner B. Am J Gastroenterol. 2006 Dec; 101(12):2857-65.

Reviews

There are no reviews yet.

Be the first to review “Cytomegalovirus (CMV)”

Your email address will not be published. Required fields are marked *